Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
35.83
+0.90 (2.58%)
Oct 29, 2025, 1:17 PM EDT - Market open
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$6,594,278
Market Cap
4.03B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36 | 9 | 33.33% |
| Dec 31, 2023 | 27 | 6 | 28.57% |
| Dec 31, 2022 | 21 | 3 | 16.67% |
| Dec 31, 2021 | 18 | -2 | -10.00% |
| Dec 31, 2020 | 20 | 1 | 5.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VKTX News
- 6 days ago - Viking Therapeutics Q3 Earnings: What We Learned (And Why We Should Keep Faith) - Seeking Alpha
- 6 days ago - Viking Therapeutics: The Prime Target In The Obesity Gold Rush - Seeking Alpha
- 6 days ago - Viking Therapeutics, Inc. (VKTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 8 days ago - Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity - PRNewsWire
- 13 days ago - Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025 - PRNewsWire
- 25 days ago - Viking Therapeutics: A Speculative Buy - Seeking Alpha
- 4 weeks ago - Viking Therapeutics: Overdue For Gains - Seeking Alpha